Navigation Links
Seahorse Bioscience to Present at 2010 UBS Global Life Sciences Conference
Date:9/20/2010

Seahorse Bioscience to Present at 2010 UBS Global Life Sciences Conference -- N. BILLERICA, Mass., Sept. 20 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Trade Show News Click to view news release full screen  

Seahorse Bioscience to Present at 2010 UBS Global Life Sciences Conference

 

N. BILLERICA, Mass., Sept. 20 /PRNewswire/ -- Seahorse Bioscience, Inc., the leading manufacturer of instruments and consumables for measuring cellular metabolism announced today that Chief Executive Officer, Jay Teich, will present at the 2010 UBS Global Life Sciences Conference on Tuesday, September 21, 2010 at 4:00 p.m. EDT at the Grand Hyatt Hotel in New York City.  Mr. Teich will highlight the company's strategy for maintaining rapid growth of 85% CAGR in a new $1BB Life Science Cellular Bioenergetics market.  "We believe that we are at the right place at the right time to ride a wave of interest in cell bioenergetics as it applies to Cancer, Obesity, Diabetes, Ageing and Cardiovascular function," proclaimed Mr. Teich.

A live webcast of the conference can be viewed at http://cc.talkpoint.com/ubsx001/092110a_lv/

About Seahorse Bioscience Seahorse XF instruments are the new standard in cellular bioenergetic measurements.  More than 600 scientists in 20 countries are utilizing the award-winning XF Analyzers to advance their research into the role of mitochondrial (dys)function and its implications in diseases.  Founded in 2001, Seahorse is headquartered in Billerica, MA.  For more information, visit http://www.seahorsebio.com.Seahorse Bioscience, Inc.Media Contact: Cynthia EganPhone: 978.671.1610
'/>"/>

SOURCE Seahorse Bioscience, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. TheScientist Awards Seahorse XF96 Analyzer a Top Ten Innovation for 2009
2. Seahorse Bioscience to Present Novel Cellular Bioenergetics Data in Collaboration with University of Nebraska at AACR Metabolism and Cancer Conference
3. New Cellular Bioenergetics Workshops Series Inaugurated by Seahorse Bioscience with Two of the Worlds Leading Bioenergetics Researchers
4. Seahorse Bioscience, Inc. Acquires BioProcessors Corp.
5. Regado Biosciences to Present at the UBS Global Life Sciences Conference on September 22, 2010 in New York City
6. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
7. EUCODIS Bioscience Appoints Two Industry Executives to Realigned Advisory Board
8. Cardio3 BioSciences Publishes the Science Basis for C-Cure(R) in JACC
9. Signum Biosciences Names Braham Shroot as Chief Executive Officer
10. YM BioSciences announces conclusion of Phase I dose-escalation and expansion of ongoing CYT387 Phase I/II clinical study
11. CORRECTED: Ampio Pharmaceuticals Announces Completion of Negotiations for Acquisition of DMI BioSciences, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... Clinovo , the cloud-based ... Electronic Data Capture (EDC) system ClinCaptureand its new Contract Research Organization (CRO) Partner ... Conference in San Mateo, California on February 10th and 11th. Watch 2-min ...
(Date:2/9/2016)... ... February 09, 2016 , ... PharmApprove ... for the National Organization for Rare Disorders (NORD). Dorman will lead PharmApprove efforts ... are heard throughout the drug regulatory review process. , “Adding Diane Dorman is ...
(Date:2/9/2016)... February 9, 2016 Three-Year Initiative Supports ... to Take Part in Life-Changing Camp ... designed to positively affect the lives of children born with rare ... --> SHPG ) is announcing a new initiative designed to ... well as the future of rare disease care. --> ...
(Date:2/8/2016)... Pa. , Feb. 8, 2016 Should ... standard bone cement products to prevent infection after standard ... that the experts at ECRI Institute have been fielding ... Infection or Fighting Your Bottom Line?" ... Your Bottom Line?" --> While ...
Breaking Biology Technology:
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
(Date:2/2/2016)... RESTON, Va. , Feb. 2, 2016 /PRNewswire/ ... contract award from the U.S. Army Research Office ... extend the range and sensitivity of the company,s ... DoD,s Past Accounting Mission and, more generally, defense-related ... its DNA phenotyping capabilities (predicting appearance and ancestry ...
(Date:2/1/2016)... 2016 Rising sales of consumer ... touchfree intuitive gesture control market size ... of consumer electronics coupled with new technological advancements to ... size through 2020   --> ... technological advancements to drive global touchfree intuitive gesture control ...
Breaking Biology News(10 mins):